Literature DB >> 34035930

An unusual case of neutrocytic, culture-negative meningitis in an immunocompetent adult.

Kundoly V Suseela1, Firosh Khan2, Santhosh J Kottoor3.   

Abstract

Patient presenting with fever, acute onset seizure and neck stiffness on examination; deteriorating despite initiation of early treatment for meningitis.
© The Author(s) 2021.

Entities:  

Keywords:  Naegleria fowleri; Primary amoebic meningoencephalitis; miltefosine; neurologic infection; seizure

Year:  2021        PMID: 34035930      PMCID: PMC8127596          DOI: 10.1177/20542704211009354

Source DB:  PubMed          Journal:  JRSM Open        ISSN: 2054-2704


Case report

A 62-year-old retired businessman from Thrissur district of Kerala, India, presented to the emergency room with a chief complaint of sudden onset generalised tonic clonic seizures. He had recurrent episodes of vomiting the previous night on a background of fever and headache for the past two days. The fever was low to moderate grade, partially relieved with over-the-counter acetaminophen tablets. The headache that started along with the fever had increased in severity over the past 24 h and was associated with projectile vomiting and photophobia. His medical history was only significant for type 2 diabetes mellitus which was well controlled on oral medications. Being born and brought up in Kerala, he had settled here with family a few years back to enjoy his retired life. He was active and used to go for walking in the morning, visiting temples and swimming in ponds. He had no history of recent travel or exposure to communicable diseases. His medications included metformin 500 mg twice daily and glimepiride 1 mg daily. On examination, he was stuporous and not responding to commands with a Glasgow Coma Scale of 10. His temperature was 99°F, heart rate 110 beats per minute, oxygen saturation 98% on room air and the blood pressure 140/90 mm Hg. There was no oedema, pallor, cyanosis or clubbing. The neck was hyperextended and had stiffness on passive flexion. Computed tomography of the brain was essentially normal and a working diagnosis of acute meningoencephalitis with symptomatic seizures was made. A lumbar puncture was done immediately, which showed non-bloody, cloudy cerebrospinal fluid and was sent for cytological, biochemical and microbiological examination. He was started on intravenous ceftriaxone, vancomycin, ampicillin, dexamethasone and levetiracetam and was admitted in the neurology intensive care unit (Day 1). Routine blood investigations showed a white cell count of 15.0 × 109/L with 80% polymorphs, erythrocyte sedimentation rate of 44 mm/h, random blood sugar of 324 mg/dl and serum sodium of 126 mEq/L. Other parameters including the renal function test and liver function test were within normal limits. Cerebrospinal fluid study showed elevated proteins (248 mg/dl), low sugar (62 mg/dl) and leukocytosis (10,000 cells/mm3) with 90% polymorphs. But cerebrospinal fluid Gram stain and rapid bacterial antigen testing for primary agents of pyogenic meningitis like Streptococcus pneumoniae, Haemophillus influenzae b and Neisseria meningitidis were all negative. Cerebrospinal fluid sample was also sent for molecular study by cartridge-based nucleic acid amplification test in GeneXpert for Mycobacterium tuberculosis. His hyponatremia was corrected with intravenous 3% saline infusion. His chest X-ray, electrocardiogram and urine routine were within normal limits. While awaiting the culture results, his condition deteriorated further necessitating endotracheal intubation and mechanical ventilation. On the third day, the results of his cerebrospinal fluid culture and cartridge-based nucleic acid amplification test also turned out to be negative giving a picture of neutrocytic, culture-negative meningitis. Taking into consideration a rare possibility of an amoebic meningitis, a wet mount examination with 40 × bright field microscopy of the same cerebrospinal fluid sample was done and it showed numerous, motile, amoebic trophozoites suggestive of Naegleria fowleri (Figure 1; see supplementary material for the video of motile N. fowleri trophozoites on wet mount preparation). As the phase contrast microscope was not available, detailed wet mount examination could not be done. On staining with haematoxylin, the amoebae were seen with purple stained-endoplasm and unstained pseudopodia (Figure 2). A preliminary diagnosis of primary amoebic meningoencepahlitis was made. He was hence started on Amphotericin B, fluconazole, azithromycin, rifampicin and miltefosin. Despite all aggressive treatment and supportive care, the patient succumbed on the ninth day of admission.
Figure 1.

Cerebrospinal fluid wet mount of a 62-year-old Indian man showing multiple N. fowleri trophozoites with endoplasm (a) and pseudopodia (b).

Figure 2.

Haematoxylin staining of cerebrospinal fluid sample from a 62-year-old Indian man showing multiple N. fowleri trophozoites with unstained pseudopodia (a) and purple-stained endoplasm (b and c).

Cerebrospinal fluid wet mount of a 62-year-old Indian man showing multiple N. fowleri trophozoites with endoplasm (a) and pseudopodia (b). Haematoxylin staining of cerebrospinal fluid sample from a 62-year-old Indian man showing multiple N. fowleri trophozoites with unstained pseudopodia (a) and purple-stained endoplasm (b and c).

Discussion

This is a case of primary amoebic meningoencephalitis, an extremely rare and sporadic central nervous system (CNS) infection caused by N. fowleri, commonly referred to as brain eating amoeba.[1] Fresh water bodies are identified as the habitat of this pathogen.[2] There are three morphological forms for this organism such as amoeboid, flagellate and cyst; of these, amoebae are the invading forms. The organism enters the nasal passages, invades the nasal mucosa and reaches brain through the olfactory nerve.[1] The disease usually affects children and young adults who are being in good health.[3] History of contact with water as swimming or diving in ponds or streams may or may not be elicited and it depends on the conscious state of the patient. Laboratory studies of cerebrospinal fluid, like cytology, of these patients may point to bacterial meningitis and antibiotic treatment is opted for majority.[4] Even though it is termed as a rare infection, the true occurrence of these cases is not very well known. Very often they are being underdiagnosed and hence underestimated. The Centers for Disease Control and Prevention data from 1962 to 2018 show an average of just three to four cases being reported per year in the United States,[5] while an epidemiological study estimates an average of 16 deaths due to primary amoebic meningoencephalitis in the United States.[6] Only 15 cases of amoebic meningoencephalitis have been reported from India so far. Global data show only about 133 reported cases from year 1992 to 2014, out of which 10 were from India and 97% of the victims died due to the infection resulting in very few survivors.[7] Recently, few events have been reported from other parts of Kerala as well.[8] The recent increase in the number of cases could be due to better awareness of the disease and the availability of modern diagnostic facilities like polymerase chain reaction. Some also propose a change in the climate and global warming to be a cause of spike in the incidence as the free-living amoebae are thermophilic organisms.[9,10] Patients typically present with high fever, headache, nausea, vomiting and meningeal signs. Rapid progression to seizure and coma may follow and most patients die within a week. Hence, it is very essential to identify the disease at the earliest and provide prompt treatment. But it often becomes a diagnostic challenge as the initial symptoms of the disease are indistinguishable from bacterial meningitis.[11] The presence of motile amoebae in cerebrospinal fluid wet mount along with a typical history and clinical picture would most likely confirm the diagnosis. Subsequent identification of the pathogen on Wright-Geimsa staining may also be considered. In our case, we attempted staining the amoeba using haematoxylin (Figure 2). Diagnostic polymerase chain reaction, immunohistochemistry, indirect immunofluorescence or next-generation sequencing are currently available in advanced centres, which can be used for confirmation. But lack of advanced diagnostic techniques should not delay or limit the diagnosis of primary amoebic meningoencephalitis. A rapid progression of meningoencephalitis in a patient in spite of initiating protocol-based intravenous antibiotic therapy should always raise an index of suspicion for primary amoebic meningoencephalitis. N. fowleri should always be considered in any patient who has purulent meningitis without evidence of bacteria on Gram stain, antigen detection assay or culture. A cerebrospinal fluid wet mount can immediately be performed after a Gram stain to look for any motile amoeba instead of waiting for antigen detection or culture results. Several unidentified cases of primary amoebic meningoencephalitis are mostly misdiagnosed as bacterial meningitis and treated with antibiotics. Very few survivors have been reported and no specific guidelines have been published for the treatment of primary amoebic meningoencephalitis. Miltefosine, a new antiparasitic drug has been shown to be active against naegleria in vitro. Other recommended drugs are amphotericin B and rifampin. A recent study by Gharpure et al.[12] identified 381 cases of primary amoebic meningoencephalitis from 1965 to 2016. Out of the 32 survivors reported, only 7 were laboratory confirmed cases while others had a clinical picture similar to primary amoebic meningoencephalitis but confirmatory testing was not done due to technical limitations. All the seven confirmed survivors received amphotericin B and the majority received a combination of azole with rifampin, azithromycin, miltefosine and/or dexamethasone. Other factors that might have contributed for survival include early identification and treatment using these recommended antimicrobials and effective management of elevated intracranial pressure.

Conclusion

Primary amoebic meningoencephalitis is a very deadly disease with over 97% mortality rate, yet frequently misdiagnosed and undertreated. Early recognition of primary amoebic meningoencephalitis is crucial as it has a rapidly deteriorating course and has no empirical treatment options available. Wet mount preparation of cerebrospinal fluid should be routinely performed as it is a simple, fast and inexpensive method to rule out primary amoebic meningoencephalitis in patients with pyogenic meningitis if no bacterial agent is identified on Gram stain. Click here for additional data file. Supplemental material, sj-pdf-1-shr-10.1177_20542704211009354 for An unusual case of neutrocytic, culture-negative meningitis in an immunocompetent adult by Kundoly V Suseela, Firosh Khan and Santhosh J Kottoor in JRSM Open Click here for additional data file. Supplemental material, sj-pdf-2-shr-10.1177_20542704211009354 for An unusual case of neutrocytic, culture-negative meningitis in an immunocompetent adult by Kundoly V Suseela, Firosh Khan and Santhosh J Kottoor in JRSM Open
  7 in total

Review 1.  Swimming with death: Naegleria fowleri infections in recreational waters.

Authors:  Travis W Heggie
Journal:  Travel Med Infect Dis       Date:  2010-07-13       Impact factor: 6.211

2.  Fatal Naegleria fowleri infection acquired in Minnesota: possible expanded range of a deadly thermophilic organism.

Authors:  Sarah K Kemble; Ruth Lynfield; Aaron S DeVries; Dennis M Drehner; William F Pomputius; Michael J Beach; Govinda S Visvesvara; Alexandre J da Silva; Vincent R Hill; Jonathan S Yoder; Lihua Xiao; Kirk E Smith; Richard Danila
Journal:  Clin Infect Dis       Date:  2012-01-11       Impact factor: 9.079

Review 3.  Pathogenic and opportunistic free-living amoebae: Acanthamoeba spp., Balamuthia mandrillaris, Naegleria fowleri, and Sappinia diploidea.

Authors:  Govinda S Visvesvara; Hercules Moura; Frederick L Schuster
Journal:  FEMS Immunol Med Microbiol       Date:  2007-04-11

4.  Epidemiology and Clinical Characteristics of Primary Amebic Meningoencephalitis Caused by Naegleria fowleri: A Global Review.

Authors:  Radhika Gharpure; John Bliton; Alexandra Goodman; Ibne Karim M Ali; Jonathan Yoder; Jennifer R Cope
Journal:  Clin Infect Dis       Date:  2021-07-01       Impact factor: 20.999

5.  Estimation of Undiagnosed Naegleria fowleri Primary Amebic Meningoencephalitis, United States1.

Authors:  Almea Matanock; Jason M Mehal; Lindy Liu; Diana M Blau; Jennifer R Cope
Journal:  Emerg Infect Dis       Date:  2018-01       Impact factor: 6.883

6.  Lethal encounters: The evolving spectrum of amoebic meningoencephalitis.

Authors:  Sandra G Gompf; Cristina Garcia
Journal:  IDCases       Date:  2019-03-12

7.  A case report: primary amoebic meningoencephalitis in a young Zambian adult.

Authors:  Mashina Chomba; Luchenga A Mucheleng'anga; Sombo Fwoloshi; Joseph Ngulube; Mable M Mutengo
Journal:  BMC Infect Dis       Date:  2017-08-01       Impact factor: 3.090

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.